Cornell researchers have designed a new, faster form of two-photon fluorescence imaging for observing cell metabolism in real time, a method that could enable quicker screening of new therapeutic treatments. The findings were published Sept. 4 in Science Advances. The co-lead authors are former postdoctoral researcher Lu Ling, Ph.D. ’20, and doctoral student Jack Crowley, M.S. ’22.
